These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Molecular analysis of SUMF1 mutations: stability and residual activity of mutant formylglycine-generating enzyme determine disease severity in multiple sulfatase deficiency. Schlotawa L; Steinfeld R; von Figura K; Dierks T; Gärtner J Hum Mutat; 2008 Jan; 29(1):205. PubMed ID: 18157819 [TBL] [Abstract][Full Text] [Related]
3. Multiple Sulfatase Deficiency: A Disease Comprising Mucopolysaccharidosis, Sphingolipidosis, and More Caused by a Defect in Posttranslational Modification. Schlotawa L; Adang LA; Radhakrishnan K; Ahrens-Nicklas RC Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32414121 [TBL] [Abstract][Full Text] [Related]
4. Expanding the genetic cause of multiple sulfatase deficiency: A novel SUMF1 variant in a patient displaying a severe late infantile form of the disease. Jaszczuk I; Schlotawa L; Dierks T; Ohlenbusch A; Koppenhöfer D; Babicz M; Lejman M; Radhakrishnan K; Ługowska A Mol Genet Metab; 2017 Jul; 121(3):252-258. PubMed ID: 28566233 [TBL] [Abstract][Full Text] [Related]
5. Rapid degradation of an active formylglycine generating enzyme variant leads to a late infantile severe form of multiple sulfatase deficiency. Schlotawa L; Radhakrishnan K; Baumgartner M; Schmid R; Schmidt B; Dierks T; Gärtner J Eur J Hum Genet; 2013 Sep; 21(9):1020-3. PubMed ID: 23321616 [TBL] [Abstract][Full Text] [Related]
6. Multiple sulfatase deficiency is due to hypomorphic mutations of the SUMF1 gene. Annunziata I; Bouchè V; Lombardi A; Settembre C; Ballabio A Hum Mutat; 2007 Sep; 28(9):928. PubMed ID: 17657823 [TBL] [Abstract][Full Text] [Related]
7. Late infantile form of multiple sulfatase deficiency with a novel missense variant in the SUMF1 gene: case report and review. Sheth J; Shah S; Datar C; Bhatt K; Raval P; Nair A; Jain D; Shah J; Sheth F; Sheth H BMC Pediatr; 2023 Mar; 23(1):133. PubMed ID: 36959582 [TBL] [Abstract][Full Text] [Related]
8. A systematic review and meta-analysis of published cases reveals the natural disease history in multiple sulfatase deficiency. Schlotawa L; Preiskorn J; Ahrens-Nicklas R; Schiller S; Adang LA; Gärtner J; Friede T J Inherit Metab Dis; 2020 Nov; 43(6):1288-1297. PubMed ID: 32621519 [TBL] [Abstract][Full Text] [Related]
9. Recognition and ER Quality Control of Misfolded Formylglycine-Generating Enzyme by Protein Disulfide Isomerase. Schlotawa L; Wachs M; Bernhard O; Mayer FJ; Dierks T; Schmidt B; Radhakrishnan K Cell Rep; 2018 Jul; 24(1):27-37.e4. PubMed ID: 29972788 [TBL] [Abstract][Full Text] [Related]
10. Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency. Schlotawa L; Tyka K; Kettwig M; Ahrens-Nicklas RC; Baud M; Berulava T; Brunetti-Pierri N; Gagne A; Herbst ZM; Maguire JA; Monfregola J; Pena T; Radhakrishnan K; Schröder S; Waxman EA; Ballabio A; Dierks T; Fischer A; French DL; Gelb MH; Gärtner J EMBO Mol Med; 2023 Mar; 15(3):e14837. PubMed ID: 36789546 [TBL] [Abstract][Full Text] [Related]
11. Structural distortions due to missense mutations in human formylglycine-generating enzyme leading to multiple sulfatase deficiency. Meshach Paul D; Chadah T; Senthilkumar B; Sethumadhavan R; Rajasekaran R J Biomol Struct Dyn; 2018 Oct; 36(13):3575-3585. PubMed ID: 29048999 [TBL] [Abstract][Full Text] [Related]
12. A systematic cross-sectional survey of multiple sulfatase deficiency. Cappuccio G; Alagia M; Brunetti-Pierri N Mol Genet Metab; 2020 Aug; 130(4):283-288. PubMed ID: 32620537 [TBL] [Abstract][Full Text] [Related]
13. New mouse models with hypomorphic SUMF1 variants mimic attenuated forms of multiple sulfatase deficiency. Sorrentino NC; Presa M; Attanasio S; Cacace V; Sofia M; Zuberi A; Ryan J; Ray S; Petkovic I; Radhakrishnan K; Schlotawa L; Ballabio A; Lutz C; Brunetti-Pierri N J Inherit Metab Dis; 2023 Mar; 46(2):335-347. PubMed ID: 36433920 [TBL] [Abstract][Full Text] [Related]
14. A homozygous missense variant of SUMF1 in the Bedouin population extends the clinical spectrum in ultrarare neonatal multiple sulfatase deficiency. Staretz-Chacham O; Schlotawa L; Wormser O; Golan-Tripto I; Birk OS; Ferreira CR; Dierks T; Radhakrishnan K Mol Genet Genomic Med; 2020 Sep; 8(9):e1167. PubMed ID: 32048457 [TBL] [Abstract][Full Text] [Related]
18. Severe neonatal multiple sulfatase deficiency presenting with hydrops fetalis in a preterm birth patient. Schlotawa L; Dierks T; Christoph S; Cloppenburg E; Ohlenbusch A; Korenke GC; Gärtner J JIMD Rep; 2019 Sep; 49(1):48-52. PubMed ID: 31497481 [TBL] [Abstract][Full Text] [Related]
19. A novel iPSC model reveals selective vulnerability of neurons in multiple sulfatase deficiency. Pham V; Sertori Finoti L; Cassidy MM; Maguire JA; Gagne AL; Waxman EA; French DL; King K; Zhou Z; Gelb MH; Wongkittichote P; Hong X; Schlotawa L; Davidson BL; Ahrens-Nicklas RC Mol Genet Metab; 2024 Feb; 141(2):108116. PubMed ID: 38161139 [TBL] [Abstract][Full Text] [Related]
20. The human SUMF1 gene, required for posttranslational sulfatase modification, defines a new gene family which is conserved from pro- to eukaryotes. Landgrebe J; Dierks T; Schmidt B; von Figura K Gene; 2003 Oct; 316():47-56. PubMed ID: 14563551 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]